As high SMAD4 expression is a desirable predictor in patients with colorectal cancer, especially in advanced stages, determining SMAD4 expression before treatment can be used to estimate the potential benefits of the planned therapy. The gene discussed is SMAD4; the disease is colorectal cancer.